How Is The Global Edible Vaccine Market Defined?
An edible vaccine is a type of vaccine produced in genetically modified plants or animals, where the vaccine is delivered through consumption rather than by injection. These vaccines stimulate an immune response in the body when an edible plant or food, such as a fruit or vegetable, is eaten. The concept aims to offer a cost-effective and easily accessible alternative to traditional vaccines, especially in developing countries.
Edible Vaccine Global Market Report 2024 provides data on the global edible vaccine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The edible vaccine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.
How Is The Global Edible Vaccine Market Size Expected To Expand, And At What Annual Growth Rate?
The edible vaccine market has grown strongly in recent years. It will grow from $8.04 billion in 2023 to $8.77 billion in 2024, at a CAGR of 9.1%. This growth is driven by advancements in genetic engineering, challenges with traditional vaccines, advances in biopharming, the global focus on immunization, and increasing government funding. The market is expected to see strong growth, reaching $12.50 billion by 2028, at a CAGR of 9.2%. The forecasted growth is attributed to the growing demand for pandemic preparedness, advances in plant biotechnology, greater public acceptance of genetically modified foods, and the increasing need for cost-effective vaccine solutions. Trends include increased collaborations between pharmaceutical companies and biotech startups, expanded production capabilities, regulatory shifts, and the development of new edible vaccine formats.
What Are The Key Drivers Fueling Growth In The Edible Vaccine Market?
The rising prevalence of infectious diseases is driving growth in the edible vaccine market. Factors such as globalization, climate change, urbanization, and antibiotic resistance contribute to the spread of pathogens. Edible vaccines, delivered via genetically modified foods, provide a cost-effective and needle-free immunization method. For example, the CDC reported a rise in U.S. tuberculosis cases from 8,320 in 2022 to 9,615 in 2023. This growing burden of infectious diseases is propelling the edible vaccine market forward.
Get Your Free Sample of the Global Edible Vaccine Market Report
What Are The Principal Market Segments In The Global Edible Vaccine Market?
The edible vaccine market covered in this report is segmented –
1) By Type: Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Live Attenuated Vaccines, Other Types
2) By Distribution Channel: Hospitals, Veterinary Clinics, Retail Pharmacies, Online Pharmacies
3) By Application: Medical Care, Livestock, Aquaculture, Agriculture, Other Applications
4) By End User: Adults, Pediatrics, Animals
Which Emerging Market Trends Are Altering The Edible Vaccine Sector?
The edible vaccine market is focusing on innovative solutions like oral cholera vaccines (OCVs) to address global health challenges. OCVs are administered orally to prevent cholera, a severe diarrheal disease. For example, in August 2024, Bharat Biotech International Ltd., an Indian biotechnology company, launched Hillchol, a live-attenuated OCV that stimulates systemic and mucosal immunity. Requiring no cold storage, this vaccine is especially suitable for resource-limited areas, offering long-lasting protection with a single dose.
What Is The Leading Region In The Edible Vaccine Market?
North America was the largest region in the edible vaccine market in 2023. The regions covered in the edible vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
